載入...
Combined therapy (intravitreal bevacizumab plus verteporfin photodynamic therapy) versus intravitreal bevacizumab monotherapy for choroidal neovascularization due to age-related macular degeneration: a 1-year follow-up study
PURPOSE: To assess the efficacy and safety of combined intravitreal bevacizumab and low-fluency-rate photodynamic therapy (PDT) in the treatment of choroidal neovascularization (CNV) associated with age-related macular degeneration (AMD) and to compare it with intravitreal bevacizumab monotherapy. M...
Na minha lista:
發表在: | Digit J Ophthalmol |
---|---|
Main Authors: | , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Massachusetts Eye and Ear Infirmary
2016
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4990082/ https://ncbi.nlm.nih.gov/pubmed/27582675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5693/djo.01.2014.01.004 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|